| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5899861 | Diabetes Research and Clinical Practice | 2013 | 7 Pages |
Abstract
Our findings suggest that cIMT progression, in addition to baseline cIMT, is a predictor of cardiovascular events in patients with T2DM without history of cardiovascular events, and that the combination of cIMT progression and baseline cIMT has a strong predictive power for such events.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Kaede Ishikawa Okayama, Tomoya Mita, Masahiko Gosho, Risako Yamamoto, Michiko Yoshida, Akio Kanazawa, Ryuzo Kawamori, Yoshio Fujitani, Hirotaka Watada,